Exenatide (exendin-4) clinical trials: 194 trials
Page 3 of 4
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
NCT02194595 · Phase 3 · Completed
Linked paper with results
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
NCT00477581 · Phase 4 · Completed
Linked paper with results
- Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
NCT00835848 · Phase 4 · Completed
Linked paper with results
- Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
NCT02690883 · Phase 4 · Completed
Linked paper with results
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
NCT04029272 · Phase 4 · Status unknown
Linked paper with results
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
NCT02303730 · Phase 4 · Completed
Linked paper with results
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
NCT01744236 · Phase 4 · Completed
Linked paper with results
- DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2
NCT03361098 · Phase 4 · Completed
Linked paper with results
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
NCT02380521 · Phase 4 · Completed
Linked paper with results
- Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
NCT02042664 · Phase 3 · Completed
Linked paper with results
- Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
NCT02860923 · Phase 3 · Completed
Linked paper with results
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
NCT02847403 · Phase 3 · Status unknown
Linked paper with results
- Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
NCT00974272 · Phase 4 · Completed
Linked paper with results
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
NCT02621489 · Phase 4 · Completed
Linked paper with results
- Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
NCT01373216 · Phase 3 · Completed
Linked paper with results
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
NCT03007329 · Phase 4 · Completed
Linked paper with results
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
NCT00766857 · Phase 4 · Completed
Linked paper with results
- Exenatide and Brown Adipose Tissue
NCT03002675 · Phase 4 · Status unknown
Linked paper with results
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
NCT01235819 · Phase 4 · Completed
Linked paper with results
- The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
NCT03419624 · Phase 3 · Terminated
Linked paper with results
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
NCT00747968 · Phase 2/3 · Completed
Linked paper with results
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
NCT02119819 · Phase 2 · Completed
Posted results
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
NCT00518115 · Phase 2 · Completed
Posted results
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
NCT00500370 · Phase 2 · Completed
Posted results
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
NCT00943917 · Phase 2 · Completed
Posted results
- A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
NCT01104701 · Phase 2 · Completed
Posted results
- Intravenous Exenatide (Byetta) During Surgery
NCT00882050 · Phase 1/2 · Completed
Posted results
- Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
NCT02496611 · Phase 2 · Completed
Posted results
- Exenatide Once Weekly for Smoking Cessation
NCT02975297 · Phase 1/2 · Completed
Posted results
- Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
NCT00701935 · Phase 2 · Terminated
Posted results
- A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
NCT01928329 · Phase 2 · Completed
Posted results
- A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
NCT00894322 · Phase 1/2 · Completed
Posted results
- A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes
NCT02020616 · Phase 1/2 · Terminated
Posted results
- A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
NCT01255163 · Phase 2 · Terminated
Posted results
- Exenatide Once-weekly as a Treatment for Multiple System Atrophy
NCT04431713 · Phase 2 · Completed
Posted results
- Exenatide in Extreme Pediatric Obesity
NCT01237197 · Phase 2 · Completed
Posted results
- Exeantide in Type 2 Diabetes on Insulin
NCT01154933 · Phase 2 · Completed
Posted results
- Effects of Exenatide on Hypothalamic Obesity
NCT01061775 · Phase 1/2 · Completed
Posted results
- GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
NCT00886626 · Phase 2 · Completed
Posted results
- Role of Exenatide in Type 1 Diabetes
NCT00456300 · Phase 2 · Completed
Posted results
- Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
NCT00566813 · Phase 1/2 · Completed
Posted results
- Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
NCT01484873 · Phase 2 · Completed
Posted results
- Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
NCT03961256 · Phase 2 · Completed
Posted results
- Exenatide for Treating Cocaine Use Disorder
NCT04941521 · Phase 1/2 · Completed
Posted results
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
NCT00529204 · Phase 2 · Terminated
Posted results
- Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
NCT02057172 · Phase 2 · Completed
Linked paper with results
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
NCT00044694 · Phase 2 · Completed
Linked paper with results
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
NCT00382239 · Phase 2 · Completed
Linked paper with results
- Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
NCT03232112 · Phase 2 · Completed
Linked paper with results
- Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
NCT03017352 · Phase 2 · Completed
Linked paper with results